Morphologic response to chemotherapy containing bevacizumab in patients with colorectal liver metastases (CLM): A post hoc analysis of the WJOG4407G phase III study

A. Hosokawa, K. Yamazaki, C. Matsuda, S. Ueda, H. Fujii, E. Baba, S. Okamura, M. Tsuda, T. Tamura, K. Shinozaki, T. Tsushima, T. Tsuda, T. Shirakawa, H. Yamashita, S. Morita, K. Muro

研究成果: Contribution to journalArticle

元の言語英語
ページ(範囲)viii171
ジャーナルAnnals of oncology : official journal of the European Society for Medical Oncology
29
DOI
出版物ステータス出版済み - 10 1 2018

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology

これを引用

Hosokawa, A., Yamazaki, K., Matsuda, C., Ueda, S., Fujii, H., Baba, E., Okamura, S., Tsuda, M., Tamura, T., Shinozaki, K., Tsushima, T., Tsuda, T., Shirakawa, T., Yamashita, H., Morita, S., & Muro, K. (2018). Morphologic response to chemotherapy containing bevacizumab in patients with colorectal liver metastases (CLM): A post hoc analysis of the WJOG4407G phase III study. Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii171. https://doi.org/10.1093/annonc/mdy281.058